Search Results
Results found for "Andrea J Vernall"
- Navigating the Signaling Network: RTK and GPCR Crosstalk Uncovered
J., Ghassemian, M., Kufareva, I., & Ghosh, P. (2024).
- Overview of adhesion GPCRs self-activation
Embo j, 2012. 31(6): p. 1364-78. 2. Qian, Y., Ma, Z., Liu, C., Li, X., Zhu, X., Wang, N., Xu, Z., Xia, R., Liang, J., Duan, Y., Yin, H.,
- Ode to GPCRs
Dowling, J. E. Nobel Prize: Three Named for Medicine, Physiology Award. McGrath, J. C. & Bond, R. A. Sir James Whyte Black OM. 14 June 192422 March 2010. Br J Pharmacol 177, 469–489 (2020). https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.14524/. Robert J. J Leukoc Biol 70, 839–848 (2001). https://onlinelibrary.wiley.com/doi/10.1189/jlb.70.6.839/. 70.
- Class B1 GPCR Dimerization: Unveiling Its Role in Receptor Function and Signaling
Gusach, A., J. García-Nafría, and C.G.
- 📰 GPCR Weekly News, January 16 to 22, 2023
trial Salipro Biotech is attending the 3rd Advanced Therapy Showcase in Tokyo, Japan, organized by LINK-J
- Decoding β-Arrestins: from Structure to function
protein and has evolved to achieve resolutions comparable to X-ray crystallography (García-Nafría, J. H., & Lee, J.
- GPCR News Flash! Top Updates You Can't-Miss! + University CheatSheet is finally available! ❄ Dec 2 - 8, 2024
transmembrane domains modulates holo-adhesion GPCR function Szymon P Kordon , Kristina Cechova , Sumit J
- 📰 GPCR Weekly News, May 20 to 26, 2024
Extracellular signal-regulated kinases – a potential pathway for GPCR-targeted drug discovery Nicola J
- 📰 GPCR Weekly News, September 18 to 24, 2023
Deadline September 27, 2023 GPCR Events, Meetings, and Webinars October 2 - 3, 2023 | Celebrating Robert J.
- 📰 GPCR Weekly News, September 11 to 17, 2023
: Allosteric Function and Biased Signaling" at the DOT NEW October 2 - 3, 2023 | Celebrating Robert J.
- 📰 GPCR Weekly News, July 31 to August 6, 2023
Nichola J Smith's investigation: Gene expression of TAS1R taste receptors for cardiometabolic disease
- Unlocking the Future of Medicine: Advancements in GPCR Research
work on Conformational dynamics underlying atypical chemokine receptor 3 activation Michael Trogdon, J
- 📰 GPCR Weekly News, April 8 to 14, 2024
et al. for their study on Frizzleds act as dynamic pharmacological entities Marina Casiraghi, Robert J
- Adhesion GPCR Consortium Newsletter - May 2024
PMID: 38378098 Curated by Sumit J. Bandekar with help from Nathan Zaidman and Abhishek K. Singh
- 📰 GPCR Weekly News, May 6 to 12, 2024
Chakit Arora, J Silvio Gutkind, and Francesco Raimondi for their work on The landscape of cancer-rewired
- Odorant receptors – a bit of smell for drug discovery
molecules which initiate a neuronal response that drives odorant discrimination and perception (Young J.
- Glyco-sulfo hotspots in the chemokine receptor system
N-termini that mediate ligand binding and signaling (Bannert N et al. 2001; Casarosa P et al. 2005; Gao J
- 🎄 Have Yourself a Merry Little GPCRmas! ❄ Dec 9 - 15, 2024
GPCR Team This Week’s Highlights: Congratulations to Andrew Tobin for an incredible week filled with
- 📰 GPCR Weekly News, May 15 to 21, 2023
Industry News X4 Pharmaceuticals Announces $65 Million Private Placement Priced At-the-Market Andrew
- 📰 GPCR Weekly News, May 22 to 28, 2023
Andrew Hopkins, Exscientia's CEO, will speak at the University of Chicago's Distinguished Seminar Series
- 📰 GPCR Weekly News, September 4 to 10, 2023
for substance use disorders Superluminal Medicines Launches to Drug Protein Conformations in a Flash Andrew
- 📰 GPCR Weekly News, May 8 to 14, 2023
DyNAbind Announce Milestone Achievement in Collaboration to Enable DEL for Membrane Proteins Professor Andrew
- 📰 GPCR Weekly News, February 27 to March 5, 2023
computational antibody drug discovery platform Antiverse identifies therapeutic antibodies targeting GPCRs CEO Andrew
- 📰 GPCR Weekly News, December 18 to 31, 2023
Morgan Healthcare Conference Andrew Hopkins appointed CBE by HM King Charles III Voyager Therapeutics
- 📰 GPCR Weekly News, October 30 to November 4, 2023
Sosei Heptares’ Partner, Pfizer, Progresses Its GLP-1 Receptor Agonist PF-06954522 into a Phase 1 Trial Andrew
- Exciting GPCR Events for Next Year! + GPCR Weekly Rocket Launch ⦿ Oct 28 - Nov 3, 2024
receptor as a therapeutic target for substance use disorders Leigh Walker , Christopher Langmead , Andrew






